These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prevention of type 2 diabetes mellitus through inhibition of the Renin-Angiotensin system. Scheen AJ Drugs; 2004; 64(22):2537-65. PubMed ID: 15516153 [TBL] [Abstract][Full Text] [Related]
6. Insulin resistance and diabetes in the context of treatment of hypertension. Lithell HO Blood Press Suppl; 1998; 3():28-31. PubMed ID: 10321452 [TBL] [Abstract][Full Text] [Related]
8. Antihypertensive treatment of patients with diabetes and hypertension. Julius S; Majahalme S; Palatini P Am J Hypertens; 2001 Nov; 14(11 Pt 2):310S-316S. PubMed ID: 11721889 [TBL] [Abstract][Full Text] [Related]
9. Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study. Gress TW; Nieto FJ; Shahar E; Wofford MR; Brancati FL N Engl J Med; 2000 Mar; 342(13):905-12. PubMed ID: 10738048 [TBL] [Abstract][Full Text] [Related]
10. A review of chemical therapies for treating diabetic hypertension. Sarafidis PA; Alexandrou ME; Ruilope LM Expert Opin Pharmacother; 2017 Jun; 18(9):909-923. PubMed ID: 28480805 [TBL] [Abstract][Full Text] [Related]
11. Antihypertensive therapy and incidence of type 2 diabetes in an elderly cohort. Padwal R; Mamdani M; Alter DA; Hux JE; Rothwell DM; Tu K; Laupacis A Diabetes Care; 2004 Oct; 27(10):2458-63. PubMed ID: 15451916 [TBL] [Abstract][Full Text] [Related]
12. Antihypertensive therapy and insulin sensitivity: do we have to redefine the role of beta-blocking agents? Jacob S; Rett K; Henriksen EJ Am J Hypertens; 1998 Oct; 11(10):1258-65. PubMed ID: 9799045 [TBL] [Abstract][Full Text] [Related]
13. Insulin resistance as an intermediary endpoint. Lithell HO Blood Press Suppl; 1997; 2():108-12. PubMed ID: 9495638 [TBL] [Abstract][Full Text] [Related]
14. Choice of antihypertensive treatment in subjects with pre-diabetes. Is there a dream after the navigator. Eleftheriadou I; Tsioufis C; Tsiachris D; Tentolouris N; Stefanadis C Curr Vasc Pharmacol; 2011 Nov; 9(6):715-22. PubMed ID: 21470107 [TBL] [Abstract][Full Text] [Related]
19. Antihypertensive therapy and the risk of type 2 diabetes mellitus. Sowers JR; Bakris GL N Engl J Med; 2000 Mar; 342(13):969-70. PubMed ID: 10738057 [No Abstract] [Full Text] [Related]
20. The development of new-onset type 2 diabetes associated with choosing a calcium channel blocker compared to a diuretic or beta-blocker. Kuti EL; Baker WL; White CM Curr Med Res Opin; 2007 Jun; 23(6):1239-44. PubMed ID: 17559720 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]